Sanara MedTech Inc (NAS:SMTI)
$ 25.74 +0.060 (+0.24%) Market Cap: 235.88 Mil Enterprise Value: 270.64 Mil PE Ratio: 0 PB Ratio: 33.56 GF Score: 74/100

Q1 2026 Sanara Medtech Inc Earnings Call Transcript

May 12, 2026 / 12:00 PM GMT
Release Date Price: $20.44 (+13.43%)

Key Points

Positve
  • Sanara MedTech Inc (SMTI) reported a 19% revenue growth in Q1 2026 compared to Q1 2025, driven by increased sales of soft tissue repair products.
  • The company achieved GAAP net profitability with a net income of $0.4 million or $0.04 per diluted share.
  • Gross margin improved by approximately 100 basis points to 93% of net revenue, indicating strong operational efficiency.
  • Sanara MedTech Inc (SMTI) expanded its sales team to 43 representatives and increased its distributor network to over 450, enhancing market reach.
  • The company is not subject to reimbursement risk due to its focus on the surgical setting, providing a predictable and reliable revenue stream.
Negative
  • The first quarter is historically the slowest sales period, and a three-day weather-related shutdown in January impacted operations.
  • Operating expenses increased by 12% year-over-year, primarily due to higher selling, general, and administrative expenses.
  • R&D expenses decreased, which could impact future innovation and product development.
  • The company has $46.2 million in long-term debt, slightly up from $46 million at the end of 2025, indicating a need for careful debt management.
  • Higher interest expenses and fees related to term loans and equity method investments contributed to increased other expenses.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SMTI.OQ - Sanara Medtech Inc
Q1 2026 Sanara Medtech Inc Earnings Call
May 12, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for participating in today's conference call to discuss Sunera MedTech's financial results for the first quarter ended March 31st, 2026. At this time, all participants are in a listen-only mode.

A question-and-answer session will follow the formal presentation.

If anyone should require operator assistance during the conference, please press star zero on your telephone keypad.

Please note that this conference call is being recorded and a replay will be available on the Investor Relations page of the company's website shortly.

The company issued its earnings release yesterday evening.

On today's call are Seth Yun, President and Chief Executive Officer,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot